FIC - Training in malaria research in Uganda
| ISRCTN | ISRCTN13964268 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN13964268 |
| Protocol serial number | N/A |
| Sponsor | Fogarty International Center (FIC) (USA) |
| Funder | Fogarty International Centre (FIC) (USA) (grant ref: TW007375) |
- Submission date
- 13/11/2005
- Registration date
- 02/12/2005
- Last edited
- 18/03/2008
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Justus Byarugaba
Scientific
Scientific
Makerere Univeristy
Faculty of Medicine
Department of Pediatrics and Child Health
P.O. Box 7072
Kampala
-
Uganda
| Phone | +256 75 696 633 |
|---|---|
| byarugabaj@yahoo.com |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Randomised double blind clinical trial |
| Secondary study design | Randomised controlled trial |
| Scientific title | |
| Study acronym | FIC |
| Study objectives | The proportion of convulsions terminated by buccal midazolam is higher than the proportion of convulsions terminated by rectal diazepam in children. |
| Ethics approval(s) | Ethics approved received from: 1. The Makerere University Medical School Research and Ethics Review Board (Uganda) 2. National Council of Science and Technology Institutional Review Board (IRB) (Uganda) 3. University of California San Francisco Institutional Review Board (IRB) (USA) |
| Health condition(s) or problem(s) studied | Prolonged convulsions |
| Intervention | Rectal diazepam versus buccal placebo |
| Intervention type | Drug |
| Phase | Not Specified |
| Drug / device / biological / vaccine name(s) | Midazolam, diazepam |
| Primary outcome measure(s) |
Time taken to terminate convulsion within 10 minutes without re-occurence of the convulsion in an hour. |
| Key secondary outcome measure(s) |
1. Time taken to re-occurence of convulsion after initial control |
| Completion date | 20/05/2006 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Child |
| Lower age limit | 3 Months |
| Upper age limit | 12 Years |
| Sex | All |
| Target sample size at registration | 350 |
| Key inclusion criteria | 1. Age between 3 months to 12 years 2. Admission to Acute Care Unit during the study period 3. A child who presents to the Acute Care Unit with convulsions 4. Provision of informed consent to continue participation in the study |
| Key exclusion criteria | 1. Documented evidence of having recieved parenteral anticonvulsant in the past 24 hours 2. Cessation of convulsion before adminstration of study drug 3. Parent/caretaker verbally declines to participate in the study |
| Date of first enrolment | 20/11/2005 |
| Date of final enrolment | 20/05/2006 |
Locations
Countries of recruitment
- Uganda
Study participating centre
Makerere Univeristy
Kampala
-
Uganda
-
Uganda
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Results article | Results | 01/01/2008 | Yes | No |